Winner Medical Stock Hits Day Low of CNY 31.48 Amid Price Pressure

Winner Medical Co., Ltd., a large-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 4.59% on March 23, 2026, reaching an intraday low of CNY 31.48. This performance comes amid broader market trends, as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Winner Medical's stock has decreased by 7.64%, and its one-month performance shows a decline of 8.3%. The stock has faced significant challenges over the past year, with a loss of 29.74%, contrasting sharply with the 13.33% gain of the China Shanghai Composite. Year-to-date, the stock is down 15.96%, and its three-year performance reflects a substantial drop of 51.82%. Financial metrics indicate that Winner Medical has struggled with long-term growth, evidenced by a net sales annual growth rate of -0.32% and an operating profit decline of 22.62% over the last five years. Despite these challenges, the company maintains a return on equity of 7.92% and a price-to-book ratio of 0.57, suggesting a valuation that may attract attention in the market.